Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Adenosine receptor A2a | ||
Ligand | BDBM561421 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Adenosine A2A Receptor Cyclic AMP GS Assay | ||
Ki | <10±n/a nM | ||
Citation | Huang, T; Wang, X Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors US Patent US11390624 Publication Date 7/19/2022 | ||
More Info.: | Get all data from this article, Assay Method | ||
Adenosine receptor A2a | |||
Name: | Adenosine receptor A2a | ||
Synonyms: | A2A adenosine receptor (hA2A) | AA2AR_HUMAN | ADENOSINE A2 | ADENOSINE A2a | ADORA2 | ADORA2A | Adenosine A2A receptor (A2AAR) | ||
Type: | G Protein-Coupled Receptor (GPCR) | ||
Mol. Mass.: | 44716.46 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P29274 | ||
Residue: | 412 | ||
Sequence: |
| ||
BDBM561421 | |||
n/a | |||
Name | BDBM561421 | ||
Synonyms: | 3-(4-amino-2-((3-fluoropyridin-2-yl)methyl)-7-(4-methyloxazol-5-yl)-2H-[1,2,3]triazolo[4,5-c]pyridin-6-yl)benzonitrile | US11390624, Example 36 | ||
Type | Small organic molecule | ||
Emp. Form. | C22H15FN8O | ||
Mol. Mass. | 426.4059 | ||
SMILES | Cc1ncoc1-c1c(nc(N)c2nn(Cc3ncccc3F)nc12)-c1cccc(c1)C#N |(2.55,2.32,;1.09,2.8,;.61,4.26,;-.93,4.26,;-1.41,2.8,;-.16,1.9,;-.16,.36,;-1.49,-.41,;-1.49,-1.95,;-.16,-2.72,;-.16,-4.26,;1.17,-1.95,;2.64,-2.43,;3.54,-1.18,;5.08,-1.18,;5.85,.15,;7.39,.15,;8.16,1.48,;7.39,2.82,;5.85,2.82,;5.08,1.48,;3.54,1.48,;2.64,.06,;1.17,-.41,;-2.83,.36,;-2.83,1.9,;-4.16,2.67,;-5.5,1.9,;-5.5,.36,;-4.16,-.41,;-6.83,-.41,;-8.16,-1.18,)| | ||
Structure |